Aspirus Cancer Care-Antigo-Volm Cancer Center — Antigo, Wisconsin

Aspirus Cancer Care-Antigo-Volm Cancer Center is a clinical research site located in Antigo, Wisconsin, United States 54409.

Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.

Aspirus Cancer Care-Antigo-Volm Cancer Center has participated in 51 clinical trials with 49 currently active.

Therapeutic areas: Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Antigo

Browse all research sites in Wisconsin · View every site in Antigo

Sponsor Feasibility Report

Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Aspirus Cancer Care-Antigo-Volm Cancer Center?

Aspirus Cancer Care-Antigo-Volm Cancer Center has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Aspirus Cancer Care-Antigo-Volm Cancer Center conducted?

Aspirus Cancer Care-Antigo-Volm Cancer Center has 51 clinical trials on record, with 49 currently active. Their work covers Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.

Is Aspirus Cancer Care-Antigo-Volm Cancer Center accredited by Crixeo Clinical Trials?

Aspirus Cancer Care-Antigo-Volm Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Aspirus Cancer Care-Antigo-Volm Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.